Gregory S. Moss's most recent trade in Evommune Inc. was a trade of 14,223 Common Stock done at an average price of $1.7 . Disclosure was reported to the exchange on May 28, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Evommune Inc | Mr. Gregory S. Moss | Chief Business & Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.71 per share. | 28 May 2026 | 14,223 | 75,058 | - | 1.7 | 24,321 | Common Stock |
| Evommune Inc | Mr. Gregory S. Moss | Chief Business & Legal Officer | 28 May 2026 | 14,223 | 47,845 | - | - | Employee Stock Option (Right to Buy) | ||
| Evommune Inc | Mr. Gregory S. Moss | Chief Business & Legal Officer | Sale of securities on an exchange or to another person at price $ 22.83 per share. | 28 May 2026 | 14,223 | 60,835 | - | 22.8 | 324,711 | Common Stock |
| Evommune Inc | Mr. Gregory S. Moss | Chief Business & Legal Officer | 16 Apr 2026 | 115,279 | 115,279 | - | - | Employee Stock Option (Right to Buy) | ||
| Evommune Inc | Mr. Gregory S. Moss | Chief Business & Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.84 per share. | 09 Dec 2025 | 13,624 | 60,835 | - | 17.8 | 243,052 | Common Stock |
| Evommune Inc | Mr. Gregory S. Moss | Chief Business & Legal Officer | 07 Nov 2025 | 25,000 | 0 | - | - | Series B Preferred Stock | ||
| Evommune Inc | Mr. Gregory S. Moss | Chief Business & Legal Officer | 07 Nov 2025 | 3,175 | 3,175 | - | - | Common Stock | ||
| Evommune Inc | Mr. Gregory S. Moss | Chief Business & Legal Officer | 05 Nov 2025 | 293,496 | 293,496 | - | - | Employee Stock Option (Right to Buy) |